🖤 Donations of all sizes power our public service journalism Give Now

Health professionals wonder about future of COVID drugs as federal funding wanes

Jun 29, 2022
Drugmaker Eli Lilly will supply the government with another 150,000 doses of its monoclonal antibody to meet short-term demand.
A free monoclonal antibody treatment site in Miami. Eli Lilly said it will provide more of its antibody medication to the government, but drugmakers may shift their sales to the commercial market.
Joe Raedle/Getty Images

Antibody treatments for COVID help, but cost is high on all sides

Sep 24, 2021
The treatment itself can be pricey, but also requires nurses and doctors who could be pulled from other units. And, availability could be strained.
Rows of beds and their letter designations are seen in a tent used for monoclonal antibody treatment of COVID-19 patients outside of St. Claire Regional Medical Center on September 16, 2021 in Morehead, Kentucky.
Jon Cherry/Getty Images